Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

215 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Prognosis of differentiated thyroid cancer in relation to serum thyrotropin and thyroglobulin antibody status at time of diagnosis.
McLeod DS, Cooper DS, Ladenson PW, Ain KB, Brierley JD, Fein HG, Haugen BR, Jonklaas J, Magner J, Ross DS, Skarulis MC, Steward DL, Maxon HR, Sherman SI; The National Thyroid Cancer Treatment Cooperative Study Group. McLeod DS, et al. Among authors: sherman si. Thyroid. 2014 Jan;24(1):35-42. doi: 10.1089/thy.2013.0062. Epub 2013 Sep 4. Thyroid. 2014. PMID: 23731273 Free PMC article.
Comparison of radioiodine biokinetics following the administration of recombinant human thyroid stimulating hormone and after thyroid hormone withdrawal in thyroid carcinoma.
Luster M, Sherman SI, Skarulis MC, Reynolds JR, Lassmann M, Hänscheid H, Reiners C. Luster M, et al. Among authors: sherman si. Eur J Nucl Med Mol Imaging. 2003 Oct;30(10):1371-7. doi: 10.1007/s00259-003-1230-1. Epub 2003 Jul 15. Eur J Nucl Med Mol Imaging. 2003. PMID: 12856155 Clinical Trial.
A comparison of short-term changes in health-related quality of life in thyroid carcinoma patients undergoing diagnostic evaluation with recombinant human thyrotropin compared with thyroid hormone withdrawal.
Schroeder PR, Haugen BR, Pacini F, Reiners C, Schlumberger M, Sherman SI, Cooper DS, Schuff KG, Braverman LE, Skarulis MC, Davies TF, Mazzaferri EL, Daniels GH, Ross DS, Luster M, Samuels MH, Weintraub BD, Ridgway EC, Ladenson PW. Schroeder PR, et al. Among authors: sherman si. J Clin Endocrinol Metab. 2006 Mar;91(3):878-84. doi: 10.1210/jc.2005-2064. Epub 2006 Jan 4. J Clin Endocrinol Metab. 2006. PMID: 16394083 Clinical Trial.
Management guidelines for patients with thyroid nodules and differentiated thyroid cancer.
Cooper DS, Doherty GM, Haugen BR, Kloos RT, Lee SL, Mandel SJ, Mazzaferri EL, McIver B, Sherman SI, Tuttle RM; American Thyroid Association Guidelines Taskforce. Cooper DS, et al. Among authors: sherman si. Thyroid. 2006 Feb;16(2):109-42. doi: 10.1089/thy.2006.16.109. Thyroid. 2006. PMID: 16420177 Free article. No abstract available.
Iodine biokinetics and dosimetry in radioiodine therapy of thyroid cancer: procedures and results of a prospective international controlled study of ablation after rhTSH or hormone withdrawal.
Hänscheid H, Lassmann M, Luster M, Thomas SR, Pacini F, Ceccarelli C, Ladenson PW, Wahl RL, Schlumberger M, Ricard M, Driedger A, Kloos RT, Sherman SI, Haugen BR, Carriere V, Corone C, Reiners C. Hänscheid H, et al. Among authors: sherman si. J Nucl Med. 2006 Apr;47(4):648-54. J Nucl Med. 2006. PMID: 16595499 Free article. Clinical Trial.
Outcomes of patients with differentiated thyroid carcinoma following initial therapy.
Jonklaas J, Sarlis NJ, Litofsky D, Ain KB, Bigos ST, Brierley JD, Cooper DS, Haugen BR, Ladenson PW, Magner J, Robbins J, Ross DS, Skarulis M, Maxon HR, Sherman SI. Jonklaas J, et al. Among authors: sherman si. Thyroid. 2006 Dec;16(12):1229-42. doi: 10.1089/thy.2006.16.1229. Thyroid. 2006. PMID: 17199433
Subacute thyroiditis causing thyroid storm.
Sherman SI, Ladenson PW. Sherman SI, et al. Thyroid. 2007 Mar;17(3):283. doi: 10.1089/thy.2007.0070. Thyroid. 2007. PMID: 17381366 No abstract available.
215 results